Raven Review Canada 2026: Women's GLP-1 Weight Loss Clinic

Canada's GLP-1 telehealth market has expanded rapidly since 2023, but nearly every major platform operates as a general-population service. Raven is the exception - built specifically for women, with clinical content, assessment tools, and support infrastructure designed around female physiology and health context. This review is based on publicly available pricing data, patient-reported outcomes on third-party review platforms, and comparison research conducted in June 2026. Raven is not currently an affiliate partner of WeightLossInjections.ca and no commission is earned from referrals to getraven.com.

What Is Raven?

Raven is a Canadian telehealth clinic operating at getraven.com, focused exclusively on weight management for women. It is operated by Phoenix Digital Health Inc., a Canadian digital health company that also operates Phoenix - a men's health telehealth clinic. The two platforms share operational infrastructure but are positioned and designed as entirely separate products for their respective patient populations.

The women-only positioning is more than marketing. Raven's intake assessment covers health areas specific to women - including menstrual cycle patterns, polycystic ovary syndrome (PCOS), perimenopause and menopause status, history of hormonal contraceptive use, and pregnancy history. These factors all influence GLP-1 therapy appropriateness and dosing, and general-population intake forms frequently do not capture them with the same depth.

From an operational standpoint, Raven is a fully asynchronous telehealth service. There are no required video consultations. Patients complete an online intake form, upload relevant health documentation, and a licensed Canadian physician reviews the submission and responds - typically within 24 hours on business days. This asynchronous model is common among GLP-1 telehealth platforms in Canada and makes the process accessible to patients with schedule constraints.

How the Program Works

Raven uses a four-stage process from initial assessment to ongoing refills. The entire intake is completed online - there are no clinic visits, no in-person requirements, and no mandatory phone or video calls.

The asynchronous model means no scheduling, no waiting rooms, and no calendar coordination. For many patients this is a practical advantage - particularly for patients with demanding work schedules or those in smaller communities where time zone differences with telehealth providers can complicate video appointments.

Raven's reported average weight loss is 13 lbs per month based on self-reported patient data. Self-reported figures are not independently audited and should be treated as directional rather than clinically validated. The clinical literature for semaglutide and tirzepatide generally shows 5-15% total body weight reduction over 68 weeks at therapeutic doses (STEP 1 trial: semaglutide 14.9% mean body weight reduction; SURMOUNT-1 trial: tirzepatide up to 20.9% at 15 mg).

Pricing and Costs

Raven does not publish medication pricing on its website. Costs are disclosed during the assessment process after a patient has completed their intake. This is a deliberate design choice that is common among GLP-1 telehealth platforms but is a source of genuine frustration in patient reviews - some patients report feeling that pricing is only revealed after they have already invested time completing the intake.

Based on patient-reported pricing data aggregated from third-party review platforms and health forums as of June 2026, monthly medication costs through Raven are estimated at $300-600 per month depending on medication type, dose, and any promotional discounts applied. Discounts of up to $200 off have been reported for first-month enrollments.

The pricing gap between Raven's estimated $300-600 range and Felix or Maple's published ~$149/month for generic semaglutide is the primary quantitative weakness in Raven's overall score. If Raven is prescribing brand-name Ozempic or Mounjaro rather than generic semaglutide, the higher price is not unusual by market standards - brand-name Ozempic retails at $200-330/month and Mounjaro at $350-630/month across most Canadian pharmacies. The key issue is that patients cannot confirm which they will be prescribed before completing the intake.

Generic Semaglutide in Canada

The Canadian generic semaglutide landscape changed materially in May 2026 when Apotex launched the first Health Canada-approved generic version of semaglutide. Prior to this, semaglutide was only available in brand-name form (Ozempic for diabetes management, Wegovy for weight management). The generic version uses the same active molecule and delivery mechanism as Ozempic but is priced substantially lower.

Approximate retail pricing for generic semaglutide as of June 2026 at in-person Canadian pharmacies: Costco approximately $88-99 per month, Walmart approximately $95-110 per month, Shoppers Drug Mart approximately $100-120 per month. These prices require an existing prescription from a physician but do not include any ongoing clinical support, dose management, or delivery.

It is not publicly confirmed whether Raven currently prescribes the Apotex generic or limits prescriptions to brand-name medications. Patients who ask about generic semaglutide specifically during their Raven intake assessment may be able to clarify this before committing. Given that several competitors including Felix and MyRocky now offer generic semaglutide through their programs at $149/month all-in, this is a material question for price-sensitive patients considering Raven.

Province Coverage

Raven serves nine Canadian provinces, consistent with the coverage area of its parent company Phoenix Digital Health Inc. Quebec and all Canadian territories (Northwest Territories, Nunavut, and Yukon) are not served. Competitors Felix and MyRocky differ in Quebec coverage - Felix does not serve Quebec, while MyRocky does, as does Maple.

The nine-province footprint covers the vast majority of the Canadian population outside Quebec. Raven's coverage of New Brunswick gives it a marginal advantage over Felix Health in Atlantic Canada, though MyRocky and Maple both also serve New Brunswick.

Medications Available Through Raven

Raven offers the broadest medication menu of any Canadian GLP-1 telehealth platform currently reviewed on this site. Both semaglutide-based and tirzepatide-based options are available, which is unusual - most platforms in Canada prescribe semaglutide only or have limited tirzepatide access.

The inclusion of both Mounjaro and Zepbound (tirzepatide formulations) sets Raven apart from Felix Health, which primarily offers semaglutide options. For patients who have not responded adequately to semaglutide or who prefer tirzepatide based on clinical trial data, Raven's formulary is a meaningful advantage. Rybelsus (oral semaglutide) is also available for patients who prefer to avoid injections - though its bioavailability and weight loss efficacy are lower than the injectable forms at comparable doses.

Final medication selection is at the physician's discretion based on your clinical assessment. Not all medications will be available to all patients - contraindications, coverage eligibility, and individual clinical factors will influence the prescribing decision.

What Patients Say

Raven holds a 4.0 out of 5 rating on Trustpilot from more than 230 verified reviews as of June 2026. This places it solidly in the "Good" category by Trustpilot's own scale, though below the 4.5+ ratings of some competitors.

Common themes in positive reviews:Fast intake process, on-time refills with no gaps in medication supply, discreet packaging that arrives without identifying healthcare branding on the outside, and a sense that the platform understands women's health concerns better than general-population platforms. Several reviewers specifically cited PCOS-related weight management as a reason for choosing Raven over a general telehealth service.

Common themes in negative reviews: Pricing surprise - multiple reviewers noted that costs disclosed during or after the intake were higher than they expected based on competitor pricing they had researched. A subset of reviewers reported difficulty reaching support when questions arose about billing or refill timing. A smaller number reported that they felt the intake was completed without being able to ask questions before a prescription decision was made.

The 4.0/5 Trustpilot average is a reasonable score for a specialized telehealth provider. The pricing-related complaints are consistent with what would be expected when a platform does not publish pricing upfront - expectation mismatches are more common when patients cannot benchmark costs before committing their time to an intake.

Raven vs Felix vs Maple - Comparison

Felix Health is Raven's closest structural competitor among the platforms reviewed here - both are asynchronous, both offer free intake assessments, and both provide home delivery. The key differentiators are Raven's women-only positioning and broader medication formulary on one hand, versus Felix's published pricing and potentially lower medication costs on the other. For a detailed Felix comparison, see our Compare GLP-1 Clinics section.

Typical Weight Loss Timeline on GLP-1 Therapy

Weight loss on GLP-1 medications follows a predictable trajectory based on the clinical trial literature. The following is based on pooled data from the STEP 1 trial (semaglutide 2.4 mg) and SURMOUNT-1 trial (tirzepatide 15 mg) rather than Raven-specific patient data, which is self-reported.

Who Raven Is Best For

Raven is most likely to be the right platform for a specific patient profile. It is not the optimal choice for everyone, and for price-sensitive patients or those comfortable with general-population telehealth, alternatives may offer better value.

Raven is likely a strong fit if you: Are a woman who specifically wants a women-only clinical environment. Have been previously prescribed semaglutide without adequate response and want access to tirzepatide (Mounjaro). Have PCOS, are perimenopausal, or have other hormonal factors that you want a specialist to consider in your weight management plan. Prefer injectable GLP-1 but want the option of switching to oral semaglutide (Rybelsus) if injection fatigue becomes a factor. Are located in New Brunswick where Felix does not operate. Are willing to pay a premium for a medication menu that includes all five major options.

Raven is likely not the best fit if you: Are primarily focused on minimizing monthly cost. Want to know exactly what you will pay before completing an intake. Are located in Quebec. Have no preference for a women-specific platform and primarily want the most affordable access to generic semaglutide.

Who Should NOT Use Raven

Pros and Cons

Verdict

Raven earns a 7.3 out of 10 in our independent scoring. The women-only clinical model and five-medication formulary are genuine differentiators in a market where most platforms offer semaglutide and little else. The free intake assessment and discreet delivery are strong operational features.

The 7.3 score rather than a higher one reflects two material issues. First, pricing opacity is a real patient experience problem that affects trust - in a market where competitors publish exact pricing on their websites, choosing to withhold that information until after a patient has invested 10 minutes completing a health questionnaire is a disadvantage. Second, the estimated $300-600/month cost range is significantly above the $149/month all-in pricing now available from competitors offering generic semaglutide with ongoing support.

For women who have already tried semaglutide without success and want access to tirzepatide through a women-specific platform, Raven may justify its higher price point. For women starting GLP-1 therapy for the first time who primarily want affordable, evidence-backed access, comparing Felix Health or MyRocky alongside Raven before committing is a reasonable approach.

Frequently Asked Questions

Is Raven a legitimate company?

Yes. Raven is operated by Phoenix Digital Health Inc., a Canadian-registered digital health company that also operates the Phoenix men's clinic. Both platforms use licensed Canadian physicians for assessment and prescribing. Raven operates under the same regulatory framework as other Canadian telehealth GLP-1 providers - prescribing physicians must be licensed in the province where the patient is located, and prescriptions must be filled by a licensed Canadian pharmacy. The platform's 230+ Trustpilot reviews provide a reasonable signal of operational legitimacy.

Does insurance cover Raven prescriptions?

Whether your private insurance plan covers GLP-1 medications prescribed through Raven depends entirely on your specific plan terms. Most Canadian private insurers require prior authorization for GLP-1 medications used for weight management. Coverage for Ozempic is more common under diabetic drug plans; Wegovy coverage is more limited. Tirzepatide (Mounjaro, Zepbound) coverage varies significantly by insurer and plan tier. Raven does not directly bill insurers - you would pay upfront and submit receipts for reimbursement. Confirm your plan coverage before starting therapy. See our insurance guide for more detail.

How fast does Raven ship medication?

After a prescription is issued, Raven ships through a partner pharmacy network with estimated delivery of 3-5 business days. Shipping is free. Packaging is temperature-controlled for injectable medications (Ozempic, Wegovy, Mounjaro pens require refrigeration) and discreet - no identifiable health branding on the exterior of the package. Delivery times may vary in more remote communities or during peak periods.

Can men use Raven?

No. Raven is a women-only platform by design. Men seeking GLP-1 telehealth services in Canada can access Phoenix (operated by the same parent company, Phoenix Digital Health Inc.), Felix Health, MyRocky, Maple, or Hims Canada. See our provider comparison for a current overview of options.